Jiangsu Hengrui Medicine (600276 CH) - Q3 Performance Improved with Promising Innovative Pipeline
This article analyzed Hengrui's Q3 performance, strengths in innovation, promotion and internationalization, as well as its forecast and rating.
527 Views
China Onshore Credit: Default Rate to Rise on Coronavirus Outbreak?
The coronavirus outbreak is expected to particularly hit the F&B, retail, travel and transportation sectors in China. The loss of operating...
536 Views
Shanghai/​​Shenzhen Connect Ideas: Home Appliances & Hard Liquors (2019-08-23)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
717 Views